The DOI matches its Crossref record.
Validation study of villous atrophy and small intestinal inflammation in Swedish biopsy registers
Open accessAbstract
BACKGROUND: Small intestinal biopsy with villous atrophy (VA) is the gold standard for the diagnosis of celiac disease (CD). We validated VA (Marsh 3) and small intestinal inflammation without VA (Marsh 1+2) in Swedish regional biopsy registers. METHODS: All pathology departments in Sweden (n = 28) were searched to identify individuals with VA or duodenal/jejunal inflammation. The validation consisted of blinded examination of biopsy samples, manual review of biopsy reports, web surveys, and patient chart reviews of 121 individuals with VA and 39 with inflammation. RESULTS: We identified 29,148 individuals with VA and 13,446 individuals with inflammation. In a blinded examination, Swedish pathologists correctly classified 90% of biopsies with VA. Manual screening of 1,534 biopsy reports (performed by co-author JFL and a research assistant) found that comorbidity other than CD was rare. IBD was the most common comorbidity and occurred in 0.3% of biopsies with VA (1.6% in inflammation). Among 114 patients with VA and available data, 108 (95%) had a clinical diagnosis of CD. 79% of the validated individuals with VA and 64% of those with inflammation had documented gastrointestinal symptoms prior to biopsy. 88% of the validated individuals with VA had positive CD serology before their first biopsy. 172/180 (96%) of Swedish gastroenterologists and 68/68 (100%) of pediatricians perform a small intestinal biopsy in at least 9 out of 10 individuals prior to diagnosis of CD. CONCLUSION: Regional biopsy data are feasible to identify individuals with CD and small-intestinal inflammation. The specificity of CD is high in villous atrophy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Small-Intestinal Histopathology and Mortality Risk in Celiac Disease
Ludvigsson, J. F. (2009) · JAMA · doi:10.1001/jama.2009.1320 · Cited by 363
Self-citationCeliac disease and non-celiac gluten sensitivity
Lebwohl, B., Ludvigsson, J. F., & Green, P. H. R. (2015) · BMJ · doi:10.1136/bmj.h4347 · Cited by 308
Self-citationLebwohl, B., Granath, F., Ekbom, A., Smedby, K. E., Murray, J. A., Neugut, A. I., Green, P. H. R., & Ludvigsson, J. F. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-3-201308060-00006 · Cited by 264
Self-citationAntibiotic exposure and the development of coeliac disease: a nationwide case–control study
Mårild, K., Ye, W., Lebwohl, B., Green, P. H., Blaser, M. J., Card, T., & Ludvigsson, J. F. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-109 · Cited by 175
Self-citationIncreased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease
Reilly, N. R., Lebwohl, B., Hultcrantz, R., Green, P. H. R., & Ludvigsson, J. F. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.013 · Cited by 110
“Among potential explanations are the lack of treatment with a glutenfree diet (in a patient chart validation we have previously found that only 2/39 (5%) randomly selected individuals with Marsh 1–2 had been advised to adhere to a gluten-free diet [27]), that Marsh 1–2 represent other forms of inflammation/autoimmunit…”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Ludvigsson, J. F., Brandt, L., Montgomery, S. M., Granath, F., & Ekbom, A.
- Venue
- BMC Gastroenterology
- Published
- 2009-03-11
- Volume
- 9
- Issue
- 1
- Pages
- 19-19
- ISSN
- 1471-230X (ISSN-L)
- OpenAlex
- W2059842582
- Cited by
- 183
- References
- 0
- FWCI
- 13.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Validation study of villous atrophy and small intestinal inflammation in Swedish biopsy registers. https://app.cochat.ai/papers/10.1186/1471-230x-9-19
- The paper
- Ludvigsson, J. F., Brandt, L., Montgomery, S. M., Granath, F., & Ekbom, A. (2009). Validation study of villous atrophy and small intestinal inflammation in Swedish biopsy registers. BMC Gastroenterology. https://doi.org/10.1186/1471-230x-9-19
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.